MAP2K2 and melanoma: To test the hypothesis that MEK1 and MEK2 are redundant and interchangeable for melanoma cell proliferation, we first evaluated the necessity of MEK1 or MEK2 signaling for melanoma cell proliferation by siRNA-mediated knockdown.